IEFM
LFCR icon

IQ EQ Fund Management’s Lifecore Biomedical LFCR Stock Holding History

IQ EQ Fund Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-255,126
Closed -$2.83M – 221
2021
Q4 		$2.83M Buy
255,126
+40,170
+19% +$390K 0.43% 85
2021
Q3 		$1.98M Sell
214,956
-1,872
-0.9% -$20.4K 0.3% 104
2021
Q2 		$2.44M Buy
216,828
+89,245
+70% +$1.03M 0.37% 99
2021
Q1 		$1.35M Buy
127,583
+108,348
+563% +$1.22M 0.24% 140
2020
Q4 		$209K Buy
+19,235
New +$199K 0.05% 223

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IQ EQ Fund Management's LFCR Position: Q1 2022 in Review

IQ EQ Fund Management sold out of Lifecore Biomedical (LFCR) in Q1 2022, closing a stake of 255,126 shares — an estimated $2.83M sold.

IQ EQ Fund Management first reported a position in LFCR in Q4 2020 and held it in 5 quarters. The position peaked at $2.83M in Q4 2021. 97 funds tracked by Wall St. Rank hold LFCR as of Q1 2022.

  • IQ EQ Fund Management reported no remaining Lifecore Biomedical position as of Q1 2022 after selling out during the quarter.
  • IQ EQ Fund Management sold 255,126 Lifecore Biomedical shares in Q1 2022, an estimated $2.83M.
  • IQ EQ Fund Management first reported a position in Lifecore Biomedical in Q4 2020 and held it in 5 quarters.
  • IQ EQ Fund Management's Lifecore Biomedical position peaked at $2.83M in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2022.

Based on IQ EQ Fund Management's 13F filing for Q1 2022, filed 28 Apr 2022.